SKP2 and central nervous system cancer: First, we examined the efficiency and specificity of the Skp2 LOF approach in C6 glioma cells, where Skp2 siRNA lentivirus-mediated transduction led to a reproducible decrease in Skp2 protein (Fig 7A) and transcript (Fig 7B) levels, compared to controls.